News
The Hon. Susan Illston approved the selection of KSF as lead counsel for the putative class in Meysam Moradpour v. Velodyne Lidar Inc., et. al.
The Hon. Arthur J. Tarnow entered an Order preliminarily approving a $18,250,000 class action settlement on behalf of all Persons who purchased or otherwise acquired Esperion common stock between August 18, 2015 and September 28, 2015.
On April 22, 2021, the Hon. Janis L. Sammartino entered an Order preliminarily approving a $4,800,000 class action settlement on behalf of all Persons who purchased or otherwise acquired Orexigen publicly-traded securitiesbetween March 3, 2015 and May 12, 2015.
On May 19, 2021, the Hon. Cormac J. Carney approved the selection of KSF as Lead Counsel for the putative class in Sam Farrar v. Workhorse Group, Inc. et al.,
Final judgment and order in the consolidated Health Insurance Innovations Securities Litigation was entered approving a $2.8 million recovery for investors.
The Hon. Thomas P. Barber, United States District Court Judge for the Middle District of Florida, entered an Order preliminarily approving a $2,800,000 class action settlement on behalf of all Persons or entities who purchased or otherwise acquired HIIQ publicly-traded securities between August 4, 2017 and September 11, 2017, inclusive.
The Hon. Arthur J. Tarnow issued an Order granting Plaintiffs’ motion for class certification in its entirety in Dougherty v. Esperion Therapeutics, Inc.
The Hon. J. Paul Oetken, United States District Court Judge for the Southern District of New York, entered an Order preliminarily approving a $1,600,000 class action settlement in Intellipharmaceutics Securities Litigation
The Hon. Kathleen Kay of the Western District of Louisiana approved the selection of KSF as Lead Counsel for the putative class in Welch v. Meaux, et al.
The Hon. Lucy H. Koh of the Northern District of California approved the selection of KSF as Lead Counsel for the putative class in In Re Cloudera Securities Litigation.
The Hon. Lucy H. Koh of the Northern District of California approved the selection of KSF as Lead Counsel for the putative class in Ikeda v. Baidu, Inc.
A three-judge panel for the Second Circuit Court of Appeals vacated in-part the dismissal order of Hon. William H. Pauley III, reviving investors’ Exchange Act claims against NewLink Genetics Corp.
The Honorable R. Steven Whalen certified a class of shareholders in Dougherty v. Esperion Therapeutics, Inc. et al, No. 2:16-cv-10089, a securities fraud class action involving Defendants’ materially misleading statements and omissions concerning a cardiovascular outcomes trial for the Company’s lead drug candidate.
The Hon. William J. Martini, United States District Judge for the District of New Jersey, entered an Order denying Defendants’ motion to dismiss against Honeywell, and individual defendants Darius Adamczyk, and Thomas A. Szlosek.
KSF approved as Co-Lead Counsel for the Class in Bellingham v. Qudian Inc. et al. Plaintiffs allege that Defendants made materially false and misleading statements and failed to disclose material information regarding the negative effect developments in China’s regulatory environment had on Qudian’s business and operations.
The Honorable Lorna G. Schofield certified a class of shareholders of Chicago Bridge & Iron Company N.V. (“CB&I”) in a lawsuit arising from Defendants’ alleged material misrepresentations and omissions regarding the performance of, and accounting relating to, CB&I’s nuclear business.
The Hon. Alvin K. Hellerstein, United States District Judge for the Southern District of New York, ordered KSF’s appointment as lead counsel for the class in In re Pareteum Securities Litigation, Case No. 1:19-cv-09767-AKH-GWG (S.D.N.Y.).
The Hon. William J. Martini, United States District Judge for the District of New Jersey, ordered KSF’s appointment as lead counsel for the class in Kanefsky v. Honeywell International Inc. et al.,
The United States District Court for the Southern District of California entered an order denying in large part defendants’ motion to dismiss. The Hon. Janis L. Sammartino found that Lead Plaintiff’s allegations gave rise to a strong inference of scienter with respect to materially misleading statements and omissions. This successful result was obtained after KSF prevailed in the Ninth Circuit Court of Appeals and in the United States Supreme Court.
The Hon. Elizabeth A. Kovachevich denied Defendant Health Insurance Innovations’ motion to dismiss, in part. Judge Kovachevich found Lead Plaintiff’s allegations that the company’s 2017 10-Q Second Quarter Report was misleading because it (i) conveyed the false impression that HII would not need a third party administrator (“TPA”) license to conduct its third-party insurance business in its home state of Florida and, (ii) misrepresented the reasons that the Florida Office of Insurance Regulation denied its application for a TPA license well plead.